MedPath

Treating listening difficulties in children with attention challenges: extension trial

Not Applicable
Recruiting
Conditions
Attention deficit
Listening difficulties
Ear - Other ear disorders
Mental Health - Learning disabilities
Registration Number
ACTRN12623000512628
Lead Sponsor
niversity of Melbourne
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Participants must have consented to participation in, and completed, the parent RCT trial
- Aged 6-12 years
- Normal hearing and middle ear function
- Presenting concerns of listening difficulties
- Evidence of attention deficits - either a diagnosis of ADHD and/or scoring outside normal limits on a behavioural assessment of auditory and visual attention (conducted routinely at initial auditory processing assessment)
- Participant and at least one caregiver have sufficient English to complete study outcomes, understand and comply with study requirements and to communicate any adverse effects.
- Has a legally acceptable parent/guardian capable of understanding the informed consent document and providing consent on the participant’s behalf.

Exclusion Criteria

- School/teachers unwilling to participate
- Hearing loss or abnormal middle ear function
- Full scale IQ < 70 as measured using the Tests of Non-Verbal Intelligence, forth edition (TONI-4) (conducted routinely at initial auditory processing assessment)
- Starting secondary/high school before the conclusion of the trial
- Planned changes to ADHD medication or dosage during the trial

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Auditory attention assessed using the Integrated visual and auditory quick screen continuous performance task (IVA-QS)[ Trial extension baseline and conclusion (30 school weeks post-baseline). ];Visual attention assessed using the Integrated visual and auditory quick screen continuous performance task (IVA-QS)[ Trial extension baseline and conclusion (30 school weeks post-baseline). ]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath